[ RECIPIENT ENTITY RECORD ]

Abiomed

VERIFIED NODE ID: 001333 · abiomed
R TARGET NODE — CAPITAL RECIPIENT
Abiomed
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Abiomed
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Abiomed is a pioneer in medical technology, specializing in circulatory support and heart recovery devices. Based in Massachusetts, the company develops the Impella heart pump, which is used to treat patients with heart failure. It is a primary destination for institutional healthcare capital and strategic pharmaceutical acquisitions.

Capital Influx Log (Transactions)
Date Type Amount
19 May 2026 EQUITY $16.6B